Ancient Herb's modern derivative targets silent liver epidemic
NCT ID NCT07199933
Summary
This study is testing whether a drug called diacerein can help treat metabolic fatty liver disease (MAFLD), a common condition where fat builds up in the liver. Researchers will give either diacerein or a placebo (inactive pill) to 74 adults with MAFLD to see if the drug reduces liver fat and improves related health measures. The drug is derived from a component of rhubarb, a traditional Chinese medicine long used for liver disorders.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAFLD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.